Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago global brewer (NYSE: TAP) ~$11.7B FY2024 revenue; Coors Light/Miller Lite Bud Light boycott beneficiaries, Coors Banquet cultural renaissance, premiumization competing with ABI and Constellation.
Molson Coors Beverage Company is a Chicago, Illinois-based global brewer and beverage company — publicly traded on the New York Stock Exchange (NYSE: TAP) as an S&P 500 Consumer Staples component — brewing and selling beer and flavored beverages through iconic brands including Coors Light, Miller Lite, Coors Banquet, Blue Moon, Molson Canadian, Carling, and hard seltzers through approximately 17,000 employees in over 30 countries. In fiscal year 2024, Molson Coors reported net sales of approximately $11.7 billion with underlying pretax income growth driven by premiumization mix shift and cost management, as the company continued executing its Revitalization Plan to grow net sales per hectoliter through premium brand investment and above-premium portfolio expansion. CEO Gavin Hattersley's strategy capitalized on the 2023 Bud Light controversy — Anheuser-Busch InBev's Dylan Mulvaney partnership backlash triggered a historic consumer boycott that shifted an estimated 2-3 share points of mainstream US beer volume from Bud Light to Coors Light and Miller Lite in 2023-2024 — representing the largest beer market share shift in decades, as Molson Coors brands became the beneficiary of Bud Light's largest-ever US sales decline. Molson Coors accelerated above-premium brand investment (Peroni Nastro Azzurro, Blue Moon LightSky, Simply Hard Lemonade partnership with Coca-Cola) to capture volume shift at higher margin price points while the two mainstream brands (Coors Light and Miller Lite) absorbed the incremental mainstream volume from Bud Light share loss.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.